18 February 2021 - Viatris announced today that Health Canada has approved Hulio, and product is now available in Canada. ...
16 February 2021 - Hyrimoz for use in nine indications covered by the reference medicine in the fields of rheumatology, gastro-enterology ...
1 February 2021 - This novel formulation provides an alternative administration option for Canadian physicians and their patients. ...
17 December 2020 - Hyrimoz approved for use in all same indications as reference medicine* including rheumatology, gastro-enterology and dermatology. ...
9 December 2020 - Valeo Pharma announced today that Health Canada has issued a Notice of Compliance for Redesca and ...
9 June 2020 - These two approvals mark an important milestone for Sandoz Canada, bringing its biosimilars into oncology at a ...
14 November 2019 - Valeo Pharma announced today that the new drug submission filed for a low molecular weight heparin ...
10 September 2019 - Celltrion said that Health Canada has given the go-ahead for Herzuma (trastuzumab), an anticancer antibody biosimilar, ...
4 September 2019 - Health Canada recently updated its fact sheet on biosimilars, including new or clarified information about key ...
22 May 2019 - Ogivri is a part of Mylan's robust portfolio of 20 biosimilar and insulin analog products. ...
10 April 2019 - Teva Canada announces that Health Canada has granted a notice of compliance for Truxima (rituximab), the ...
28 February 2019 - First-ever pegfilgrastim biosimilar approved by Health Canada launches across the country. ...
18 February 2019 - Health Canada has announced that all biologics, including biosimilars, will be identified by their brand names and ...
21 January 2019 - Erelzi is the only etanercept biosimilar to be indicated for reducing the signs and symptoms of psoriatic ...